Effect of Transcranial Direct-current Stimulation Therapy on Primary Chronic Insomnia Patients
- Conditions
- Primary Insomnia
- Interventions
- Device: transcranial Direct Current Stimulation
- Registration Number
- NCT02832804
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
To evaluate the clinical efficacy and safety of neuromodulation by transcranial direct current stimulation (tDCS) in the patients with primary chronic insomnia .
- Detailed Description
* visit 1
* to fill in a questionnaire (Clinical Global Impression, CGI; Leeds Sleep Evaluation Questionnaire, LSEQ; Stanford Sleepiness Scale, SSS; Hospital Anxiety and Depression Scale, HADS; 36-Item Short Form Survey, SF-36)
* EEG
* visit 2-6
* tDCS stimulation (monday \~ friday)
* anodal / cathodal / sham
* to fill in a questionnaire (CGI, LSEQ, SSS, HADS)
* analysis the results of sleep log and actigraphy
* visit 7 : 1 week after treatment
* to fill in a questionnaire (CGI, LSEQ, SSS, HADS)
* analysis the results of sleep log and actigraphy
* EEG
* visit 8 : 1 month after treatment
* to fill in a questionnaire (CGI, LSEQ, SSS, HADS, SF-36)
* analysis the results of sleep log
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8
- adult (older than 19 years)
- primary insomnia
- right handed
- agree with participation of this study
- diagnosed with epilepsy or history of seizure
- change of antipsychotic drug within 1 month
- under suspicion of sleep apnea or periodic limb movement disorder
- mental retardation (IQ < 70)
- pregnant woman
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description anodal stimulation transcranial Direct Current Stimulation 10 person The patients treated by anodal stimulation (2mA) for 20 minutes cathodal stimulation transcranial Direct Current Stimulation 10 person The patients treated by cathodal stimulation (1-2mA) for 20 minutes sham stimulation transcranial Direct Current Stimulation 10 person The patients treated by anodal stimulation (1-2mA) for 15 seconds
- Primary Outcome Measures
Name Time Method sleep log and actiwatch Change from baseline at 1 week Changes of sleep quality
- Secondary Outcome Measures
Name Time Method questionnaire Change from baseline at 1 month EEG spectrum analysis Change from baseline at 1 month Number of Participants with Adverse Events as a Measure of Safety and Tolerability Change from baseline at 1 month
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of